Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

Philippe Debourdeau, MD, Marc Espié, MD, Sylvie Chevret, MD PhD, Joseph Gligorov, MD PhD, Antoine Elias, MD PhD, Pierre Francois Dupré, MD, Joel Le Long, MD, Sandrine Lavau-Denes, MD, Marie-Antoinette Sevestre, MD PhD, Laurent Bastit, MD, Issa Kalidi, MD, Corinne Frere, MD PhD, Dominique Farge, MD PhD

Blood (2016) 128 (22): 2607.

https://doi.org/10.1182/blood.V128.22.2607.2607

Published: 2016

Journal Articles

Long-Term Use of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Patients’ Perception in Tropique, a Prospective, Multicenter, Observational Study

Dominique Farge, PhD MD, Philippe Debourdeau, MD, Norbert Claude Gorin, MD PhD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 4272.

https://doi.org/10.1182/blood.V124.21.4272.4272

Published: 2014

Journal Articles

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Dominique Farge, PhD MD, Philippe Debourdeau, MD, Norbert Claude Gorin, MD PhD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 4273.

https://doi.org/10.1182/blood.V124.21.4273.4273

Published: 2014

Journal Articles

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

Dominique Farge, PhD MD, Norbert Claude Gorin, MD PhD, Philippe Debourdeau, MD, Anne Lamblin, Francis Cajfinger, MD

Blood (2014) 124 (21): 1545.

https://doi.org/10.1182/blood.V124.21.1545.1545

Published: 2014

Journal Articles

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Blood (2008) 112 (11): 1284.

https://doi.org/10.1182/blood.V112.11.1284.1284

Published: 2008

NARROW

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

Long-Term Use of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Patients’ Perception in Tropique, a Prospective, Multicenter, Observational Study

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Email alerts

ASH Publications

American Society of Hematology

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

Long-Term Use of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Patients’ Perception in Tropique, a Prospective, Multicenter, Observational Study

Long-Term Efficacy and Safety of Low-Molecular-Weight Heparins (LMWH) for Cancer-Associated Venous Thromboembolism (VTE) in Tropique, a Prospective Non-Interventional Observational Study

Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only